首页 > 最新文献

Radiology最新文献

英文 中文
Impact of Patient-reported Symptom Information on the Interpretation of MRI of the Lumbar Spine. 患者报告的症状信息对腰椎核磁共振成像解读的影响。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1148/radiol.233487
Rene Balza, Sarah F Mercaldo, Ambrose J Huang, Jad S Husseini, Mohamed Jarraya, F Joseph Simeone, Joao R T Vicentini, William E Palmer

Background Distinguishing lumbar pain generators from incidental findings at MRI can be difficult. Dictated reports may become lists of findings that cannot be ranked in order of diagnostic importance. Purpose To determine whether patient-reported symptom information can improve the interpretation of lumbar spine MRI by using the spine specialist as the reference standard. Materials and Methods This prospective, single-center, multireader study analyzed 240 participants who completed pre-MRI symptom questionnaires between May 2022 and February 2023. At the time of clinical MRI reporting, radiologists recorded pain generators in consecutive participants, creating two study groups by alternating interpretations with versus without symptom questionnaire results (SQR). Diagnostic certainty was recorded using a numeric scale of 0 to 100. Types, levels, and sides of pain generators were compared with reference diagnoses by calculating Cohen κ values with 95% CIs. Participant characteristics and diagnostic certainties were compared using the Wilcoxon rank sum, Pearson χ2, or Kruskal-Wallis test. Interrater agreement was analyzed. Results There was no difference in age (P = .69) or sex (P = .60) between participants using SQR (n = 120; mean age, 61.0 years; 62 female) and not using SQR (n = 120; mean age, 62.5 years; 67 female). When radiologists were compared with specialists, agreements on pain generators were almost perfect for interpretations using SQR (type: κ = 0.82 [95% CI: 0.74,0.89]; level: κ = 0.88 [95% CI: 0.80, 0.95]; side: κ = 0.84 [95% CI: 0.75, 0.92]), but only fair to moderate for interpretations not using SQR (type: κ = 0.26 [95% CI: 0.15, 0.36]; level: κ = 0.51 [95% CI: 0.39, 0.63]; side: κ = 0.30 [95% CI: 0.18, 0.42]) (all P < .001). Diagnostic certainty was higher for MRI interpretations using SQR (mean, 80.4 ± 14.9 [SD]) than MRI interpretations not using SQR (60.5 ± 17.7) (P < .001). Interrater agreements were substantial (κ = 0.65-0.78) for MRI interpretations using SQR but only fair to moderate (κ = 0.24-0.49) for MRI interpretations not using SQR (all P < .001). Conclusion Patient-reported symptom information enabled radiologists to achieve nearly perfect diagnostic agreement with clinical experts. © RSNA, 2024 See also the editorial by Isikbay and Shah in this issue.

背景 从磁共振成像的偶然发现中区分腰痛发生器可能很困难。口述报告可能会成为无法按诊断重要性排序的检查结果清单。目的 通过将脊柱专科医生作为参考标准,确定患者报告的症状信息是否能改善腰椎 MRI 的判读。材料和方法 这项前瞻性、单中心、多读取器研究分析了 2022 年 5 月至 2023 年 2 月间完成 MRI 前症状问卷调查的 240 名参与者。在临床 MRI 报告时,放射科医生记录了连续参与者的疼痛发生器,通过交替解释有症状问卷结果(SQR)和无症状问卷结果(SQR)来创建两个研究组。诊断确定性采用 0 到 100 的数字量表进行记录。通过计算 Cohen κ 值和 95% CIs,将疼痛发生器的类型、程度和侧面与参考诊断进行比较。使用 Wilcoxon 秩和检验、Pearson χ2 检验或 Kruskal-Wallis 检验比较参与者特征和诊断确定性。分析了研究者之间的一致性。结果 使用 SQR 的参与者(n = 120;平均年龄 61.0 岁;女性 62 人)与未使用 SQR 的参与者(n = 120;平均年龄 62.5 岁;女性 67 人)在年龄(P = .69)或性别(P = .60)方面没有差异。当放射科医生与专科医生进行比较时,使用 SQR 的判读几乎完全一致(类型:κ = 0.82 [95% CI:0.74,0.89];水平:κ = 0.88 [95% CI:0.80,0.95];侧面:κ = 0.84[95%CI:0.75,0.92]),而未使用 SQR 的判读结果仅为一般至中等(类型:κ = 0.26 [95% CI:0.15,0.36];水平:κ = 0.51 [95% CI:0.39,0.63];侧面:κ = 0.30 [95% CI:0.18,0.42])(所有 P <0.001)。与未使用 SQR 的 MRI 解释(60.5 ± 17.7)相比,使用 SQR 的 MRI 解释的诊断确定性更高(平均值为 80.4 ± 14.9 [标码])(P < .001)。使用 SQR 的核磁共振成像判读结果的互译一致性很高(κ = 0.65-0.78),而未使用 SQR 的核磁共振成像判读结果的互译一致性仅为一般至中等(κ = 0.24-0.49)(P < .001)。结论 患者报告的症状信息使放射科医师与临床专家的诊断几乎完全一致。RSNA, 2024 另请参阅本期 Isikbay 和 Shah 的社论。
{"title":"Impact of Patient-reported Symptom Information on the Interpretation of MRI of the Lumbar Spine.","authors":"Rene Balza, Sarah F Mercaldo, Ambrose J Huang, Jad S Husseini, Mohamed Jarraya, F Joseph Simeone, Joao R T Vicentini, William E Palmer","doi":"10.1148/radiol.233487","DOIUrl":"10.1148/radiol.233487","url":null,"abstract":"<p><p>Background Distinguishing lumbar pain generators from incidental findings at MRI can be difficult. Dictated reports may become lists of findings that cannot be ranked in order of diagnostic importance. Purpose To determine whether patient-reported symptom information can improve the interpretation of lumbar spine MRI by using the spine specialist as the reference standard. Materials and Methods This prospective, single-center, multireader study analyzed 240 participants who completed pre-MRI symptom questionnaires between May 2022 and February 2023. At the time of clinical MRI reporting, radiologists recorded pain generators in consecutive participants, creating two study groups by alternating interpretations with versus without symptom questionnaire results (SQR). Diagnostic certainty was recorded using a numeric scale of 0 to 100. Types, levels, and sides of pain generators were compared with reference diagnoses by calculating Cohen κ values with 95% CIs. Participant characteristics and diagnostic certainties were compared using the Wilcoxon rank sum, Pearson χ<sup>2</sup>, or Kruskal-Wallis test. Interrater agreement was analyzed. Results There was no difference in age (<i>P</i> = .69) or sex (<i>P</i> = .60) between participants using SQR (<i>n</i> = 120; mean age, 61.0 years; 62 female) and not using SQR (<i>n</i> = 120; mean age, 62.5 years; 67 female). When radiologists were compared with specialists, agreements on pain generators were almost perfect for interpretations using SQR (type: κ = 0.82 [95% CI: 0.74,0.89]; level: κ = 0.88 [95% CI: 0.80, 0.95]; side: κ = 0.84 [95% CI: 0.75, 0.92]), but only fair to moderate for interpretations not using SQR (type: κ = 0.26 [95% CI: 0.15, 0.36]; level: κ = 0.51 [95% CI: 0.39, 0.63]; side: κ = 0.30 [95% CI: 0.18, 0.42]) (all <i>P</i> < .001). Diagnostic certainty was higher for MRI interpretations using SQR (mean, 80.4 ± 14.9 [SD]) than MRI interpretations not using SQR (60.5 ± 17.7) (<i>P</i> < .001). Interrater agreements were substantial (κ = 0.65-0.78) for MRI interpretations using SQR but only fair to moderate (κ = 0.24-0.49) for MRI interpretations not using SQR (all <i>P</i> < .001). Conclusion Patient-reported symptom information enabled radiologists to achieve nearly perfect diagnostic agreement with clinical experts. © RSNA, 2024 See also the editorial by Isikbay and Shah in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e233487"},"PeriodicalIF":12.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
US Attenuation Coefficient for Liver Fat Quantification: A Need for Standardization. 用于肝脏脂肪定量的 US 衰减系数:需要标准化。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1148/radiol.242511
Aiguo Han
{"title":"US Attenuation Coefficient for Liver Fat Quantification: A Need for Standardization.","authors":"Aiguo Han","doi":"10.1148/radiol.242511","DOIUrl":"10.1148/radiol.242511","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e242511"},"PeriodicalIF":12.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535872/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact on Prognosis of Stage I Non-Small Cell Lung Cancer Secondary to Delays in Diagnostic Workup. 诊断工作延误对 I 期非小细胞肺癌预后的影响。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1148/radiol.240420
David F Yankelevitz, Rowena Yip, Claudia I Henschke

Background Diagnostic workup of small pulmonary nodules often requires follow-up CT scans to confirm nodule growth before invasive diagnostics or treatment. Purpose To confirm prior results from the International Early Lung Cancer Action Program (I-ELCAP) on quantifying decreases in lung cancer prognosis by using two large databases, the National Lung Screening Trial (NLST) and International Association for the Study of Lung Cancer (IASLC). Materials and Methods In this retrospective study, a model was developed to predict cure rates based on size of solid nodules using the NLST (August 2002 to summer 2007) and IASLC (January 2011 to December 2019) databases, focusing on stage I non-small cell lung cancer (NSCLC). Kaplan-Meier methods were used to calculate 10-year lung cancer-specific survival and 5-year overall survival rates for different tumor sizes. Tumor diameter increases after 90-, 180-, and 365-day delays were estimated using volume doubling times (VDTs) of 60, 120, and 240 days corresponding to fast, moderate, and slow tumor growth. Initial and delayed lung cancer cure rates were assessed across nine scenarios of time delays and tumor growth rates and compared with the previous results of the I-ELCAP database. Results Using regression models based on 166 NLST and 22 590 IASLC patients with NSCLC, 10-year lung cancer-specific survival and 5-year overall survival, respectively, for tumors 4.0-20.0 mm in diameter were estimated. For a 20.0-mm tumor with a 60-day VDT in the NLST database, the lung cancer-specific survival decreased from 83.4% to 76.5%, 66.8%, and 32.3% after 90, 180, and 365 days, respectively. The IASLC database showed similar decreases in 5-year overall survival, from 81.2% to 73.4%, 62.4%, and 23.3% after 90, 180, and 365 days, respectively. Comparison across NLST, IASLC, and I-ELCAP databases revealed minor variations in lung cancer cure rates between 79.9% and 83.4%, with reductions of 6.9%-8.3% after a 180-day delay with a 120-day VDT. Conclusion The NLST and IASLC databases confirmed prior estimates from the I-ELCAP database for the decrease in lung cancer prognosis due to diagnostic delays. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Park and Lee in this issue.

背景 肺部小结节的诊断工作通常需要进行后续 CT 扫描,以便在进行侵入性诊断或治疗之前确认结节的生长情况。目的 通过使用国家肺部筛查试验(NLST)和国际肺癌研究协会(IASLC)这两个大型数据库,证实国际早期肺癌行动计划(I-ELCAP)之前关于量化肺癌预后下降的结果。材料与方法 在这项回顾性研究中,我们利用 NLST(2002 年 8 月至 2007 年夏季)和 IASLC(2011 年 1 月至 2019 年 12 月)数据库开发了一个模型,根据实体结节的大小预测治愈率,重点关注 I 期非小细胞肺癌(NSCLC)。采用卡普兰-梅耶法计算不同肿瘤大小的10年肺癌特异性生存率和5年总生存率。使用体积倍增时间(VDT)(60、120和240天)估算了90、180和365天延迟后肿瘤直径的增加,分别对应快速、中度和慢速肿瘤生长。评估了九种延迟时间和肿瘤生长率情况下的初始和延迟肺癌治愈率,并与 I-ELCAP 数据库之前的结果进行了比较。结果 使用基于 166 名 NLST 和 22 590 名 IASLC NSCLC 患者的回归模型,分别估算了直径为 4.0-20.0 毫米的肿瘤的 10 年肺癌特异性生存率和 5 年总生存率。在 NLST 数据库中,对于 VDT 为 60 天的 20.0 毫米肿瘤,90 天、180 天和 365 天后的肺癌特异性生存率分别从 83.4% 降至 76.5%、66.8% 和 32.3%。IASLC 数据库显示,5 年总生存率也出现了类似的下降,90 天、180 天和 365 天后分别从 81.2% 降至 73.4%、62.4% 和 23.3%。对 NLST、IASLC 和 I-ELCAP 数据库进行比较后发现,肺癌治愈率在 79.9% 和 83.4% 之间略有不同,在 120 天 VDT 延迟 180 天后,治愈率下降了 6.9%-8.3% 。结论 NLST 和 IASLC 数据库证实了之前 I-ELCAP 数据库对诊断延迟导致肺癌预后下降的估计。© RSNA, 2024 这篇文章有补充材料。另请参阅本期 Park 和 Lee 的社论。
{"title":"Impact on Prognosis of Stage I Non-Small Cell Lung Cancer Secondary to Delays in Diagnostic Workup.","authors":"David F Yankelevitz, Rowena Yip, Claudia I Henschke","doi":"10.1148/radiol.240420","DOIUrl":"10.1148/radiol.240420","url":null,"abstract":"<p><p>Background Diagnostic workup of small pulmonary nodules often requires follow-up CT scans to confirm nodule growth before invasive diagnostics or treatment. Purpose To confirm prior results from the International Early Lung Cancer Action Program (I-ELCAP) on quantifying decreases in lung cancer prognosis by using two large databases, the National Lung Screening Trial (NLST) and International Association for the Study of Lung Cancer (IASLC). Materials and Methods In this retrospective study, a model was developed to predict cure rates based on size of solid nodules using the NLST (August 2002 to summer 2007) and IASLC (January 2011 to December 2019) databases, focusing on stage I non-small cell lung cancer (NSCLC). Kaplan-Meier methods were used to calculate 10-year lung cancer-specific survival and 5-year overall survival rates for different tumor sizes. Tumor diameter increases after 90-, 180-, and 365-day delays were estimated using volume doubling times (VDTs) of 60, 120, and 240 days corresponding to fast, moderate, and slow tumor growth. Initial and delayed lung cancer cure rates were assessed across nine scenarios of time delays and tumor growth rates and compared with the previous results of the I-ELCAP database. Results Using regression models based on 166 NLST and 22 590 IASLC patients with NSCLC, 10-year lung cancer-specific survival and 5-year overall survival, respectively, for tumors 4.0-20.0 mm in diameter were estimated. For a 20.0-mm tumor with a 60-day VDT in the NLST database, the lung cancer-specific survival decreased from 83.4% to 76.5%, 66.8%, and 32.3% after 90, 180, and 365 days, respectively. The IASLC database showed similar decreases in 5-year overall survival, from 81.2% to 73.4%, 62.4%, and 23.3% after 90, 180, and 365 days, respectively. Comparison across NLST, IASLC, and I-ELCAP databases revealed minor variations in lung cancer cure rates between 79.9% and 83.4%, with reductions of 6.9%-8.3% after a 180-day delay with a 120-day VDT. Conclusion The NLST and IASLC databases confirmed prior estimates from the I-ELCAP database for the decrease in lung cancer prognosis due to diagnostic delays. © RSNA, 2024 <i>Supplemental material is available for this article.</i> See also the editorial by Park and Lee in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e240420"},"PeriodicalIF":12.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142473354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Academic Radiology Physician Financial Compensation in the United States: Trends and Distribution. 美国放射科医生的经济补偿:趋势与分布。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1148/radiol.241057
Ajay Malhotra, Dheeman Futela, Rudra Joshi, Mihir Khunte, Nagaraj S Moily, Xiao Wu, Seyedmehdi Payabvash, Max Wintermark, Dheeraj Gandhi

Background The overall trends in academic radiology physician compensation are not well studied. Purpose To assess recent trends in academic radiology financial compensation and distribution based on rank, gender, race/ethnicity, and geography in U.S. medical schools. Materials and Methods This secondary analysis used deidentified data from the Association of American Medical Colleges (AAMC) Faculty Salary Report, which collects information for full-time faculty at U.S. medical schools. Financial compensation data for full-time academic radiology faculty was collected from 2017 to 2023, stratified by rank, gender, race/ethnicity, and geography. The faculty salary report includes median, 25th, and 75th percentile compensation values for each rank, which were used to analyze trends with linear regression. Median compensation values were used to compare groups based on gender, race/ethnicity, and region. Results The AAMC Faculty Salary Report data for 2023 included responses for 5847 faculty members across all radiology departments, including 306 instructors, 2758 assistant professors, 1409 associate professors, 1004 full professors, 226 chiefs, and 144 chairs. On average, median faculty compensation increased by 2.6%-4.4% per year from 2017 to 2023, with the greatest increase (by 4.4% per year) at the instructor level and smaller increases (3.4%-2.6%) at the more senior ranks. Male faculty members were consistently compensated more than women at all ranks throughout the study period. The overall salary gap remained at 6% ($455 000 for women vs $483 000 for men) throughout the study period but increased numerically from $24 000 in 2019 to $28 000 in 2023. Black/African American faculty had a lower median compensation compared with White faculty (by 4% overall; $452 000 for Black/African American faculty vs $472 000 for White faculty) at all ranks except at professor rank. Instructor compensation in the Northeast region was substantially higher (by $278 000) than other regions, but this geographic differential did not exceed $35 000 at other ranks. Conclusion This study summarized the trends of full-time academic radiology faculty compensation and showed persistent salary inequities that should be addressed as part of a broader drive to increase diversity, equity, and inclusion. © RSNA, 2024 Supplemental material is available for this article.

背景 对学术放射科医生薪酬的总体趋势研究不多。目的 根据美国医学院的级别、性别、种族/民族和地理位置,评估学术放射学经济补偿和分配的最新趋势。材料与方法 这项二次分析使用了美国医学院协会(AAMC)教职员工薪酬报告中的去标识化数据,该报告收集了美国医学院全职教职员工的信息。该报告收集了 2017 年至 2023 年放射学全职学术教师的经济补偿数据,并按职级、性别、种族/民族和地域进行了分层。教职员工薪酬报告包括各职级薪酬值的中位数、第25百分位数和第75百分位数,用于线性回归分析趋势。薪酬中值用于比较基于性别、种族/族裔和地区的组别。结果 2023 年 AAMC 教职员工薪酬报告数据包括所有放射科 5847 名教职员工的回复,其中包括 306 名讲师、2758 名助理教授、1409 名副教授、1004 名正教授、226 名主任和 144 名主任。平均而言,从 2017 年到 2023 年,教职员工薪酬中位数每年增长 2.6%-4.4% ,其中讲师级别增幅最大(每年增长 4.4%),而更高级别的增幅较小(3.4%-2.6%)。在整个研究期间,男性教职员工在所有级别上的薪酬始终高于女性。在整个研究期间,总体薪酬差距保持在 6%(女性为 455 000 美元,男性为 483 000 美元),但在数字上从 2019 年的 24 000 美元增至 2023 年的 28 000 美元。除教授职级外,黑人/非裔美国人教员在所有职级的薪酬中位数均低于白人教员(总体差距为 4%;黑人/非裔美国人教员的薪酬中位数为 452 000 美元,白人教员的薪酬中位数为 472 000 美元)。东北部地区的讲师薪酬比其他地区高出很多(高出 27.8 万美元),但在其他职级,这种地域差异不超过 3.5 万美元。结论 本研究总结了放射学全职学术教师的薪酬趋势,并显示了持续存在的薪酬不平等现象,应将其作为提高多样性、公平性和包容性的更广泛努力的一部分加以解决。© RSNA, 2024 本文有补充材料。
{"title":"Academic Radiology Physician Financial Compensation in the United States: Trends and Distribution.","authors":"Ajay Malhotra, Dheeman Futela, Rudra Joshi, Mihir Khunte, Nagaraj S Moily, Xiao Wu, Seyedmehdi Payabvash, Max Wintermark, Dheeraj Gandhi","doi":"10.1148/radiol.241057","DOIUrl":"10.1148/radiol.241057","url":null,"abstract":"<p><p>Background The overall trends in academic radiology physician compensation are not well studied. Purpose To assess recent trends in academic radiology financial compensation and distribution based on rank, gender, race/ethnicity, and geography in U.S. medical schools. Materials and Methods This secondary analysis used deidentified data from the Association of American Medical Colleges (AAMC) Faculty Salary Report, which collects information for full-time faculty at U.S. medical schools. Financial compensation data for full-time academic radiology faculty was collected from 2017 to 2023, stratified by rank, gender, race/ethnicity, and geography. The faculty salary report includes median, 25th, and 75th percentile compensation values for each rank, which were used to analyze trends with linear regression. Median compensation values were used to compare groups based on gender, race/ethnicity, and region. Results The AAMC Faculty Salary Report data for 2023 included responses for 5847 faculty members across all radiology departments, including 306 instructors, 2758 assistant professors, 1409 associate professors, 1004 full professors, 226 chiefs, and 144 chairs. On average, median faculty compensation increased by 2.6%-4.4% per year from 2017 to 2023, with the greatest increase (by 4.4% per year) at the instructor level and smaller increases (3.4%-2.6%) at the more senior ranks. Male faculty members were consistently compensated more than women at all ranks throughout the study period. The overall salary gap remained at 6% ($455 000 for women vs $483 000 for men) throughout the study period but increased numerically from $24 000 in 2019 to $28 000 in 2023. Black/African American faculty had a lower median compensation compared with White faculty (by 4% overall; $452 000 for Black/African American faculty vs $472 000 for White faculty) at all ranks except at professor rank. Instructor compensation in the Northeast region was substantially higher (by $278 000) than other regions, but this geographic differential did not exceed $35 000 at other ranks. Conclusion This study summarized the trends of full-time academic radiology faculty compensation and showed persistent salary inequities that should be addressed as part of a broader drive to increase diversity, equity, and inclusion. © RSNA, 2024 <i>Supplemental material is available for this article.</i></p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e241057"},"PeriodicalIF":12.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142352722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detecting Cellular Microstructural Changes of Liver Fibrosis with Time-Dependent Diffusion MRI. 利用随时间变化的弥散核磁共振成像检测肝纤维化的细胞微结构变化
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1148/radiol.240343
Lijie Zhang, Xi Long, Leqing Chen, Xiaoyu Han, Xiaoxiao Zhang, Peng Sun, Yuhan Yang, Jun Fan, Jiazheng Wang, Ziqiao Lei, Bin Liang, Xiaoming Liu, Heshui Shi

Background The potential of time-dependent diffusion MRI in imaging the progression from liver fibrosis to cirrhosis has not been established. Purpose To assess the effectiveness of time-dependent diffusion MRI in mapping the microstructure and characterizing cellular attributes during the progression of liver fibrosis to cirrhosis and to investigate its potential in grading liver fibrosis. Materials and Methods This prospective study, performed between December 2022 and October 2023, used 60 rats to establish a liver fibrosis model by means of diethylnitrosamine administration, with five additional rats serving as control animals. Time-dependent diffusion MRI was performed with equivalent diffusion time of 5.4, 10.7, and 69.3 msec on a 3.0-T scanner. Time-dependent diffusion MRI-based microstructural parameters, including cell diameter, intracellular volume fraction (ICVF), cellularity, and extracellular diffusivity, were estimated with use of the imaging microstructural parameters using limited spectrally edited diffusion, or IMPULSED, model. The fitted microstructural parameters were validated with histopathologic measurements. Results All 60 rats developed liver fibrosis, with a noticeable decrease in cell diameter and an increase in ICVF and cellularity observed as liver fibrosis progressed. The diameter measured at pathologic examination ranged from 11.4 μm to 35.4 μm, aligning with the range of 12.4-33.4 μm observed in time-dependent diffusion MRI, which indicated a strong correlation (r = 0.84; P < .001). The quantified ICVF at pathologic examination ranged from 0.28 to 0.89 and varied from 0.23 to 0.85 at time-dependent diffusion MRI, showing a high correlation (r = 0.62; P < .001). The cellularity observed at pathologic examination increased from 0.74 to 5.85, while the cellularity measured at time-dependent diffusion MRI ranged from 0.77 to 3.70, showing a correlation (r = 0.44; P < .001). Conclusion This study revealed the changes in quantitative microstructural mapping across the spectrum from liver fibrosis to cirrhosis. Cell diameter, ICVF, and cellularity are reliable markers for liver fibrosis, with diameter and ICVF presenting good discrimination ability. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Matos and Metens in this issue.

背景 时间依赖性弥散核磁共振成像在肝纤维化进展到肝硬化过程中的成像潜力尚未确定。目的 评估时间依赖性弥散核磁共振成像在绘制肝纤维化进展到肝硬化过程中的微观结构和细胞属性特征方面的有效性,并研究其在肝纤维化分级方面的潜力。材料与方法 这项前瞻性研究于 2022 年 12 月至 2023 年 10 月间进行,通过给大鼠注射二乙基亚硝胺,用 60 只大鼠建立肝纤维化模型,另外 5 只大鼠作为对照动物。在 3.0-T 扫描仪上以 5.4、10.7 和 69.3 毫秒的等效扩散时间进行了时间依赖性扩散核磁共振成像。通过使用有限光谱编辑扩散模型或 IMPULSED,利用成像微结构参数估算了基于时间依赖性扩散 MRI 的微结构参数,包括细胞直径、细胞内体积分数 (ICVF)、细胞度和细胞外扩散率。拟合的微结构参数与组织病理学测量结果进行了验证。结果 所有 60 只大鼠都出现了肝纤维化,随着肝纤维化的发展,细胞直径明显减小,ICVF 和细胞度增加。病理检查时测得的直径范围为 11.4 μm 至 35.4 μm,与时间依赖性弥散核磁共振成像中观察到的 12.4-33.4 μm 范围一致,两者显示出很强的相关性(r = 0.84;P < .001)。病理检查的量化 ICVF 为 0.28 至 0.89,而时间依赖性弥散 MRI 的量化 ICVF 为 0.23 至 0.85,显示出高度相关性(r = 0.62;P < .001)。病理检查观察到的细胞度从 0.74 增加到 5.85,而时间依赖性弥散核磁共振成像测量到的细胞度从 0.77 增加到 3.70,显示出相关性(r = 0.44;P < .001)。结论 本研究揭示了从肝纤维化到肝硬化整个过程中定量微结构图谱的变化。细胞直径、ICVF 和细胞度是肝纤维化的可靠标记,其中直径和 ICVF 具有良好的鉴别能力。RSNA, 2024 这篇文章有补充材料。另请参阅本期 Matos 和 Metens 的社论。
{"title":"Detecting Cellular Microstructural Changes of Liver Fibrosis with Time-Dependent Diffusion MRI.","authors":"Lijie Zhang, Xi Long, Leqing Chen, Xiaoyu Han, Xiaoxiao Zhang, Peng Sun, Yuhan Yang, Jun Fan, Jiazheng Wang, Ziqiao Lei, Bin Liang, Xiaoming Liu, Heshui Shi","doi":"10.1148/radiol.240343","DOIUrl":"https://doi.org/10.1148/radiol.240343","url":null,"abstract":"<p><p>Background The potential of time-dependent diffusion MRI in imaging the progression from liver fibrosis to cirrhosis has not been established. Purpose To assess the effectiveness of time-dependent diffusion MRI in mapping the microstructure and characterizing cellular attributes during the progression of liver fibrosis to cirrhosis and to investigate its potential in grading liver fibrosis. Materials and Methods This prospective study, performed between December 2022 and October 2023, used 60 rats to establish a liver fibrosis model by means of diethylnitrosamine administration, with five additional rats serving as control animals. Time-dependent diffusion MRI was performed with equivalent diffusion time of 5.4, 10.7, and 69.3 msec on a 3.0-T scanner. Time-dependent diffusion MRI-based microstructural parameters, including cell diameter, intracellular volume fraction (ICVF), cellularity, and extracellular diffusivity, were estimated with use of the imaging microstructural parameters using limited spectrally edited diffusion, or IMPULSED, model. The fitted microstructural parameters were validated with histopathologic measurements. Results All 60 rats developed liver fibrosis, with a noticeable decrease in cell diameter and an increase in ICVF and cellularity observed as liver fibrosis progressed. The diameter measured at pathologic examination ranged from 11.4 μm to 35.4 μm, aligning with the range of 12.4-33.4 μm observed in time-dependent diffusion MRI, which indicated a strong correlation (<i>r</i> = 0.84; <i>P</i> < .001). The quantified ICVF at pathologic examination ranged from 0.28 to 0.89 and varied from 0.23 to 0.85 at time-dependent diffusion MRI, showing a high correlation (<i>r</i> = 0.62; <i>P</i> < .001). The cellularity observed at pathologic examination increased from 0.74 to 5.85, while the cellularity measured at time-dependent diffusion MRI ranged from 0.77 to 3.70, showing a correlation (<i>r</i> = 0.44; <i>P</i> < .001). Conclusion This study revealed the changes in quantitative microstructural mapping across the spectrum from liver fibrosis to cirrhosis. Cell diameter, ICVF, and cellularity are reliable markers for liver fibrosis, with diameter and ICVF presenting good discrimination ability. © RSNA, 2024 <i>Supplemental material is available for this article.</i> See also the editorial by Matos and Metens in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e240343"},"PeriodicalIF":12.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142352724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
It Might Be Time to Get Serious about Generative AI in Radiology. 也许是时候认真对待放射学中的生成式人工智能了。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1148/radiol.242813
Paul J Chang
{"title":"It Might Be Time to Get Serious about Generative AI in Radiology.","authors":"Paul J Chang","doi":"10.1148/radiol.242813","DOIUrl":"https://doi.org/10.1148/radiol.242813","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e242813"},"PeriodicalIF":12.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142473356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial. 低剂量 CT 肺癌筛查中的肺结节管理:从 NELSON 试验中汲取的教训。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1148/radiol.240535
Danrong Zhong, Grigory Sidorenkov, Colin Jacobs, Pim A de Jong, Hester A Gietema, Ralph Stadhouders, Kristiaan Nackaerts, Joachim G Aerts, Mathias Prokop, Harry J M Groen, Geertruida H de Bock, Rozemarijn Vliegenthart, Marjolein A Heuvelmans

Screening with low-dose CT (LDCT) in a high-risk population, as defined by age and smoking behavior, reduces lung cancer-related mortality. However, LDCT screening presents a major challenge. Numerous, mostly benign, nodules are seen in the lungs during screening. The question is how to distinguish the malignant from the benign nodules. Various studies use different protocols for nodule management. The Dutch-Belgian NELSON (Nederlands-Leuvens Longkanker Screenings Onderzoek) trial, the largest European lung cancer screening trial, used distinctions based on nodule volumetric assessment and growth rate. This review discusses key findings from the NELSON study regarding the characteristics of screening-detected nodules, including nodule size and its volumetric assessment, growth rate, subtype, and their associated malignancy risk. These results are compared with findings from other screening studies and current recommendations for lung nodule management. By examining differences in nodule management strategies and providing a comprehensive overview of outcomes specific to lung cancer screening, this review aims to contribute to the broader discussion on optimizing lung nodule management in screening programs.

根据年龄和吸烟行为对高危人群进行低剂量 CT(LDCT)筛查可降低肺癌相关死亡率。然而,低剂量 CT 筛查是一项重大挑战。在筛查过程中,肺部会出现许多结节,其中大部分是良性的。问题是如何区分恶性和良性结节。不同的研究采用了不同的结节处理方案。荷兰-比利时 NELSON(Nederlands-Leuvens Longkanker Screenings Onderzoek)试验是欧洲最大的肺癌筛查试验,该试验根据结节体积评估和生长率来区分结节。本综述讨论了 NELSON 研究中关于筛查出的结节特征的主要发现,包括结节大小及其体积评估、生长率、亚型及其相关恶性风险。这些结果将与其他筛查研究的结果和当前的肺结节管理建议进行比较。通过研究结节管理策略的差异并全面概述肺癌筛查的具体结果,本综述旨在为更广泛地讨论优化筛查项目中的肺结节管理做出贡献。
{"title":"Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial.","authors":"Danrong Zhong, Grigory Sidorenkov, Colin Jacobs, Pim A de Jong, Hester A Gietema, Ralph Stadhouders, Kristiaan Nackaerts, Joachim G Aerts, Mathias Prokop, Harry J M Groen, Geertruida H de Bock, Rozemarijn Vliegenthart, Marjolein A Heuvelmans","doi":"10.1148/radiol.240535","DOIUrl":"10.1148/radiol.240535","url":null,"abstract":"<p><p>Screening with low-dose CT (LDCT) in a high-risk population, as defined by age and smoking behavior, reduces lung cancer-related mortality. However, LDCT screening presents a major challenge. Numerous, mostly benign, nodules are seen in the lungs during screening. The question is how to distinguish the malignant from the benign nodules. Various studies use different protocols for nodule management. The Dutch-Belgian NELSON (Nederlands-Leuvens Longkanker Screenings Onderzoek) trial, the largest European lung cancer screening trial, used distinctions based on nodule volumetric assessment and growth rate. This review discusses key findings from the NELSON study regarding the characteristics of screening-detected nodules, including nodule size and its volumetric assessment, growth rate, subtype, and their associated malignancy risk. These results are compared with findings from other screening studies and current recommendations for lung nodule management. By examining differences in nodule management strategies and providing a comprehensive overview of outcomes specific to lung cancer screening, this review aims to contribute to the broader discussion on optimizing lung nodule management in screening programs.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e240535"},"PeriodicalIF":12.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142473357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Making Sense of the Modern-Day Meta-Analysis. 了解现代 Meta 分析。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1148/radiol.242505
Andrew Humbert
{"title":"Making Sense of the Modern-Day Meta-Analysis.","authors":"Andrew Humbert","doi":"10.1148/radiol.242505","DOIUrl":"10.1148/radiol.242505","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e242505"},"PeriodicalIF":12.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142473358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dural Arteriovenous Fistula at Photon-Counting CT Angiography. 光子计数 CT 血管造影下的硬脑膜动静脉瘘。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1148/radiol.240954
Wen-Tian Tang, Yan-E Zhao
{"title":"Dural Arteriovenous Fistula at Photon-Counting CT Angiography.","authors":"Wen-Tian Tang, Yan-E Zhao","doi":"10.1148/radiol.240954","DOIUrl":"https://doi.org/10.1148/radiol.240954","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e240954"},"PeriodicalIF":12.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum for: Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. 勘误:MR 肠造影特征描述纤维化克罗恩病的可靠性。
IF 2.9 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1148/radiol.249020
Florian Rieder, Mark E Baker, David H Bruining, Jeff L Fidler, Eric C Ehman, Shannon P Sheedy, Jay P Heiken, Justin M Ream, David R Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S Lee, Stuart A Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wang, Julie Rémillard, Rickey E Carter, Ronald Ottichilo, Norma Atkinson, Mohamed Tausif Siddiqui, Venkata C Sunkesula, Christopher Ma, Claire E Parker, Julian Panés, Jordi Rimola, Vipul Jairath, Brian G Feagan, Joel G Fletcher
{"title":"Erratum for: Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease.","authors":"Florian Rieder, Mark E Baker, David H Bruining, Jeff L Fidler, Eric C Ehman, Shannon P Sheedy, Jay P Heiken, Justin M Ream, David R Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S Lee, Stuart A Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wang, Julie Rémillard, Rickey E Carter, Ronald Ottichilo, Norma Atkinson, Mohamed Tausif Siddiqui, Venkata C Sunkesula, Christopher Ma, Claire E Parker, Julian Panés, Jordi Rimola, Vipul Jairath, Brian G Feagan, Joel G Fletcher","doi":"10.1148/radiol.249020","DOIUrl":"10.1148/radiol.249020","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e249020"},"PeriodicalIF":2.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564889/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Radiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1